Skip to main content

Nutech Mediworld's human embryonic stem cell technology get Malaysian patent

 

Clinical courses

Nutech Mediworld, the world’s only human embryonic stem cell therapy centre based in India, announced that its human embryonic stem cell (hESC) technology developed by Dr Geeta Shroff has received 66th patent in Malaysia for the treatment of various medical conditions.  
The technology differentiates itself from other stem cell therapies in three major ways. Firstly, it has universal application, i.e. anyone and everyone can take these cells without the need for matching. Secondly, it is available in a ready to use form with a shelf life of 6 months &  can be transported easily. Thus is not clinic based. Thirdly, it has an easy non-invasive delivery mechanism and can be administered in the simple form of an injection. Due to these qualities it has the potential to be made readily available in pharmacies across the world, much like insulin.

Dr Geeta Shroff, founder and medical director of Nutech Mediworld said “This new patent establishes India as a leader in stem cell therapy as now we have developed a ready-to-use product with a shelf life of six months. Due to the enormous health benefits to the population, it is  important to make this therapy available globally, as a first line of treatment, to safely and effectively improve the quality of life of patients suffering from conditions presently labelled incurable or terminal,”

Dr Shroff’s ground breaking technology is advancing the ‘Make in India’ campaign for the biotechnology sector.  The technology is being used for treatments of many incurable diseases ranging from spinal cord injury, diabetes, ALS, cerebral palsy, stroke, Parkinson’s disease and others.

Over the last 13 years, Nutech Mediworld has treated over 1300 patients from 51countries. Conditions treated include spinal injuries, multiple sclerosis, Parkinson’s disease, diabetes, Lyme disease, cerebral palsy and autism. A number of peer-reviewed papers related to this technology have already been published in international scientific & medical journals.


<< Pharma News

Subscribe to PharmaTutor News Alerts by Email >>